Vertex Pharmaceuticals VRTX Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Vertex Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vertex Pharmaceuticals's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vertex Pharmaceuticals's total costs & expenses?
- Vertex Pharmaceuticals (VRTX) reported total costs & expenses of $1.85B in Q1 2026.
- How has Vertex Pharmaceuticals's total costs & expenses changed year-over-year?
- Vertex Pharmaceuticals's total costs & expenses decreased by 13.6% year-over-year, from $2.14B to $1.85B.
- What is the long-term trend for Vertex Pharmaceuticals's total costs & expenses?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's total costs & expenses has grown at a 13.1% compound annual growth rate (CAGR), from $4.79B to $7.83B.